학술논문

Gold compound auranofin inhibits I?B kinase (IKK) by modifying Cys-179 of IKKß subunit
Document Type
Article
Source
Experimental and Molecular Medicine; April 2003, Vol. 35 Issue: 2 p61-66, 6p
Subject
Language
ISSN
12263613; 20926413
Abstract
Antirheumatic gold compounds have been shown to inhibit NF-?B activation by blocking I?B kinase (IKK) activity. To examine the possible inhibitory mechanism of gold compounds, we expressed wild type and mutant forms of IKKa and ß subunits in COS-7 cells and determined the effect of gold on the activity of these enzymes both in vivo and in vitro. Substitution of Cys-179 of IKKß with alanine (C179A) rendered the enzyme to become resistant to inhibition by a gold compound auranofin, however, similar protective effect was not observed with an equivalent level of IKKa (C178A) mutant expressed in the cells. Auranofin inhibited constitutively active IKKa and ß and variants; IKKa (S176E, S180E) or IKKß (S177E, S181E), suggesting that gold directly cause inhibition of activated enzyme. The different inhibitory effect of auranofin on IKKa (C178A) and IKKß (C179A) mutants indicates that gold could inhibit the two subunits of IKK in a different mode, and the inhibition of NF-?B and IKK activation induced by inflammatory signals in gold-treated cells appears through its interaction with Cys-179 of IKKß.